ARTICLE | Company News
Emergent BioSolutions, Kalon Biotherapeutics, Lonza, GlaxoSmithKline, Novartis, Texas A&M University System infectious news
June 25, 2012 7:00 AM UTC
HHS's Biomedical Advanced Research and Development Authority (BARDA) will invest about $400 million to establish three private-public consortia to develop and manufacture medical countermeasures. Each...